Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, which is approved by the FDA in ovarian cancer, and Jemperli for ...
Minority patients with gynecologic cancers are more likely than White patients to receive treatment at academic facilities, a recent study found. Gynecologic cancer treatment also often requires ...
As part of the CURE® Educated Patient® Gynecologic Cancers Summit, an expert explained the basics of biomarkers and the questions they raise. Patients can benefit from clinical trials in gynecologic ...
In 2024, the American Cancer Society estimates that uterine cancer will surpass ovarian cancer in total estimated number of deaths in the United States. That’s partly due to the progress made in ...
Development and Validation of a Clinical Prediction Model for Paclitaxel Hypersensitivity Reaction on the Basis of Real-World Data: Pac-HSR Score Eligible participants comprised women age 25 years or ...
Ian C. Cook, MD, discusses the feasibility and benefits of adding bilateral salpingectomy to nongynecologic surgery.
Spirituality significantly aids stress management in gynecologic cancer patients undergoing radiation therapy, with most patients rating faith as highly important. The FICA Spiritual History Tool ...
For those who did not prescribe ET, the most common reasons were belief that hormones are contraindicated, better options exist, and risk outweighs benefits. HealthDay News — Many gynecologists and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results